Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 3
2006 1
2007 1
2009 1
2010 4
2012 2
2013 1
2014 3
2015 5
2016 3
2017 5
2018 10
2019 9
2020 10
2021 8
2022 5
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Current and emerging therapies for coeliac disease.
Kivelä L, Caminero A, Leffler DA, Pinto-Sanchez MI, Tye-Din JA, Lindfors K. Kivelä L, et al. Among authors: tye din ja. Nat Rev Gastroenterol Hepatol. 2021 Mar;18(3):181-195. doi: 10.1038/s41575-020-00378-1. Epub 2020 Nov 20. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33219355 Review.
Review article: Follow-up of coeliac disease.
Tye-Din JA. Tye-Din JA. Aliment Pharmacol Ther. 2022 Jul;56 Suppl 1(Suppl 1):S49-S63. doi: 10.1111/apt.16847. Aliment Pharmacol Ther. 2022. PMID: 35815829 Free PMC article. Review.
Reply.
Hardy MY, Anderson RP, Tye-Din JA. Hardy MY, et al. Among authors: tye din ja. Gastroenterology. 2016 Mar;150(3):779-80. doi: 10.1053/j.gastro.2016.01.027. Epub 2016 Jan 27. Gastroenterology. 2016. PMID: 26826377 No abstract available.
For celiac disease, diagnosis is not enough.
Gibson PR, Shepherd SJ, Tye-Din JA. Gibson PR, et al. Among authors: tye din ja. Clin Gastroenterol Hepatol. 2012 Aug;10(8):900-1. doi: 10.1016/j.cgh.2012.03.020. Epub 2012 Apr 10. Clin Gastroenterol Hepatol. 2012. PMID: 22503997 No abstract available.
Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study.
Tye-Din JA, Daveson AJM, Goel G, Goldstein KE, Hand HL, Neff KM, Popp A, Taavela J, Maki M, Isola J, Williams LJ, Truitt KE, Anderson RP; RESET CeD Study Group. Tye-Din JA, et al. Lancet Gastroenterol Hepatol. 2023 May;8(5):446-457. doi: 10.1016/S2468-1253(22)00428-9. Epub 2023 Mar 7. Lancet Gastroenterol Hepatol. 2023. PMID: 36898393 Clinical Trial.
Deteriorating Sprue: A New Frontier for Gastrointestinal Ultrasound.
Elford AT, Tye-Din JA, Christensen B. Elford AT, et al. Among authors: tye din ja. Gastroenterology. 2023 May;164(6):876-879. doi: 10.1053/j.gastro.2022.11.005. Epub 2022 Nov 11. Gastroenterology. 2023. PMID: 36372222 No abstract available.
67 results